Article
Hims & Hers plummets 15% after first-quarter loss, weak earnings guidance
Pessimistic
-42.1
−100 Bearish
0
+100 Bullish
Hims & Hers reached a deal with Novo Nordisk in March to sell its GLP-1 weight loss drug Wegovy on its platform.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Source
CNBC Top Stories
Published
May 12, 2026 · 12:05 pm
Article ID
0y171y7
Original URL
Open source
Sentiment Signal
Pessimistic
-42.1
−100Neutral+100
More Like This